Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction
- 31 March 1985
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 17 (3) , 339-346
- https://doi.org/10.1016/0262-1746(85)90124-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarctionAmerican Heart Journal, 1985
- Protection of Ischemic Cat Myocardium By CGS-13080, a Selective Potent Thromboxane A2 Synthesis InhibitorJournal of Cardiovascular Pharmacology, 1983
- Prevention of extension of ischaemic damage following acute myocardial ischaemia by dazoxiben, a new thromboxane synthetase inhibitor.Published by Wiley ,1983
- Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmiasNature, 1981
- Influence of thromboxane inhibition on the severity of myocardial ischemia in catsCanadian Journal of Physiology and Pharmacology, 1980
- Effect of prostaglandin endoperoxide analogue on canine renal function, hemodynamics and renin releaseEuropean Journal of Pharmacology, 1979
- Long-Term Preservation of Ischemic Myocardium after Experimental Coronary Artery OcclusionJournal of Clinical Investigation, 1978
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Endogenous formation of the prostaglandin endoperoxine metabolite, thromboxane B2, by brain tissueBiochemical and Biophysical Research Communications, 1976
- Simple Techniques for the Surgical Occlusion of Coronary Vessels in the RatAngiology, 1960